STRS Ohio’s Beam Therapeutics BEAM Stock Holding History

STRS Ohio’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.8K	Buy	+1,100	New	+$33.2K	﹤0.01%	2061
2025 Q2	–	Sell	-9,900	Closed	-$193K	–	2208
2025 Q1	$193K	Buy	9,900 +2,700	+38%	+$70.7K	﹤0.01%	1519
2024 Q4	$179K	Hold	7,200	–	–	﹤0.01%	1535
2024 Q3	$176K	Hold	7,200	–	–	﹤0.01%	1589
2024 Q2	$169K	Buy	7,200 +5,700	+380%	+$140K	﹤0.01%	1598
2024 Q1	$49K	Buy	+1,500	New	+$46.7K	﹤0.01%	1766
2023 Q2	–	Sell	-5,100	Closed	-$156K	–	1950
2023 Q1	$156K	Hold	5,100	–	–	﹤0.01%	1648
2022 Q4	$199K	Sell	5,100 -800	-14%	-$35.8K	﹤0.01%	1588
2022 Q3	$281K	Buy	5,900 +2,800	+90%	+$160K	﹤0.01%	1504
2022 Q2	$120K	Buy	3,100 +2,100	+210%	+$83.5K	﹤0.01%	1725
2022 Q1	$57K	Sell	1,000 -2,100	-68%	-$138K	﹤0.01%	1925
2021 Q4	$247K	Sell	3,100 -6,900	-69%	-$591K	﹤0.01%	1673
2021 Q3	$870K	Sell	10,000 -900	-8%	-$90.4K	﹤0.01%	1197
2021 Q2	$1.4M	Buy	10,900 +4,000	+58%	+$319K	0.01%	944
2021 Q1	$552K	Buy	6,900 +4,800	+229%	+$457K	﹤0.01%	1531
2020 Q4	$171K	Buy	+2,100	New	+$103K	﹤0.01%	1778
2020 Q2	–	Sell	-3,100	Closed	-$55K	–	2163
2020 Q1	$55K	Buy	+3,100	New	+$67.4K	﹤0.01%	1770

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

STRS Ohio's BEAM Position: Q2 2026 in Review

STRS Ohio opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 1,100 shares worth $37.8K. The stake represents ﹤0.01% of the portfolio and ranks #2061 among its holdings. This is a return to the name: STRS Ohio previously reported a position in BEAM as recently as Q1 2025.

STRS Ohio first reported a position in BEAM in Q1 2020 and has held it in 17 quarters since. The position peaked at $1.4M in Q2 2021. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

STRS Ohio held 1,100 shares of Beam Therapeutics worth $37.8K as of Q2 2026.
Beam Therapeutics was a new STRS Ohio position in Q2 2026.
Beam Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #2061 holding.
STRS Ohio first reported a position in Beam Therapeutics in Q1 2020 and has held it in 17 quarters since.
STRS Ohio's Beam Therapeutics position peaked at $1.4M in Q2 2021.
278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.